Overview
APM market data
Price History
APM price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.19 Diluted earnings per share over the trailing twelve months.
- Beta
- -0.03 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -1,115.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $6.00 – $44.70 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $5.7M · P/B 0.37 · P/S 4.75.
Company News
8-K filing — Niki BioSolutions, Inc. (APM)SEC EDGAR · Jul 20, 2026, 12:15 PM
Aptorum Group shares are trading lower after the company announced its merger with DiamiR Biosciences is expected to close on or about July 20, alongside a 1-to-10 reverse stock split.Benzinga · Jul 16, 2026, 6:09 PM
Aptorum Group Announces 1-For-10 Reverse Stock Split, Effective July 20; Proposed Merger With DiamiR Biosciences Anticipated To Close Around July 20Benzinga · Jul 16, 2026, 3:03 PM
Aptorum Group Announces Collaboration Between DiamiR And AlzLabs Precision Diagnostics To Generate Protein And MicroRNA Blood-Based Biomarker Data With Focus On Alzheimer's DiseaseBenzinga · Jun 22, 2026, 12:15 PM